Kliniske studier for Hemofili i Florida
6 studier for Hemofili søker deltakere på steder i Florida.
Byer i Florida
Offisiell studietekst (engelsk)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- USF Health Morsani Center For Advanced Healthcare, Tampa
- The University of South Florida Board of Trustees, Tampa
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT05568719A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- St Joseph's Children's Hospital of Tampa, Tampa
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- og 4 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Johns Hopkins All Children's Hospital, St. Petersburg
RekruttererObservasjonsstudie
Alder 6 til 19 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT05022459Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- University of Miami Miller School of Medicine, Miami
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 2. jun. 2026 · NCT03695978Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- University of Miami - Miller School of Medicine, Coral Gables
- St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders, Tampa
RekruttererFase 1
Alder 0 til 90 · Alle kjønn · Oppdatert 3. apr. 2026 · NCT05500807Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.